Greywolf Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$31.2M |
| 2 |
ZINC
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
|
+$11.5M |
| 3 |
MannKind Corp
MNKD
|
+$5.65M |
| 4 |
RBY
RUBICON MENERALS CORP (F)
RBY
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.31% |
| 2 | Industrials | 19.49% |
| 3 | Materials | 5.01% |
| 4 | Financials | 0% |
Similar funds
Greywolf Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Greywolf Capital Management held 10 positions worth $565M, down 37% from $899M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Greywolf Capital Management withdrew a net $334M in Q4 2014, closing 1 position and reducing 1 holding. Its most notable exit was American International, an estimated $26.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 8.8% a quarter earlier, followed by Industrials and Materials.
Against the trend, Greywolf Capital Management opened a new position in AMAG Pharmaceuticals worth $35.9M.
- Greywolf Capital Management's largest Q4 2014 buy was AMAG Pharmaceuticals: 863,105 shares worth $35.9M.
- Greywolf Capital Management added most to HORSEHEAD HLDG CORP COM STK (DE) in Q4 2014, an estimated $11.5M increase.
- Greywolf Capital Management fully exited American International in Q4 2014, selling an estimated $26.6M.
- Greywolf Capital Management's ten largest holdings make up 100% of its $565M portfolio in Q4 2014.
- Greywolf Capital Management opened 1 new position and closed 1 in Q4 2014.
- Greywolf Capital Management's portfolio value fell 37% quarter-over-quarter to $565M.
Based on Greywolf Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.